Search by Drug Name or NDC

    NDC 10599-0003-01 Sinuva 1350 ug/1 Details

    Sinuva 1350 ug/1

    Sinuva is a INTRASINAL IMPLANT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Intersect ENT, Inc.. The primary component is MOMETASONE FUROATE.

    Product Information

    NDC 10599-0003
    Product ID 10599-003_508796b2-418c-402f-a33f-5766a8d4c18b
    Associated GPIs 42200045102350
    GCN Sequence Number 078014
    GCN Sequence Number Description mometasone furoate IMPLANT 1350 MCG NASAL
    HIC3 Q7P
    HIC3 Description NASAL ANTI-INFLAMMATORY STEROIDS
    GCN 44214
    HICL Sequence Number 003329
    HICL Sequence Number Description MOMETASONE FUROATE
    Brand/Generic Brand
    Proprietary Name Sinuva
    Proprietary Name Suffix n/a
    Non-Proprietary Name mometasone furoate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form IMPLANT
    Route INTRASINAL
    Active Ingredient Strength 1350
    Active Ingredient Units ug/1
    Substance Name MOMETASONE FUROATE
    Labeler Name Intersect ENT, Inc.
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA209310
    Listing Certified Through 2024-12-31

    Package

    NDC 10599-0003-01 (10599000301)

    NDC Package Code 10599-003-01
    Billing NDC 10599000301
    Package 1 POUCH in 1 CARTON (10599-003-01) / 1 IMPLANT in 1 POUCH
    Marketing Start Date 2018-02-01
    NDC Exclude Flag N
    Pricing Information N/A